Progressive multifocal leucoencephalopathy (PML) is a subacute demyelinating disease of the central nervous system, which was first recognised by Astrom et al.V In almost all cases JC virus was found.' In two, possibly five patients, a related virus, SV 40 , was identified as the causative agent. ' . As yet, a third polyomavirus, BKV, has not been associated with PML.
PML is thought to be an opportunistic infection developing against a background of impaired immune responses, either iatrogenic or due to other diseases. 3 49 It has been recognised, however, in patients without any apparent predisposing factor.3 4 PML is distributed worldwide as is JC virus, and can occur at any age.34 Although still distinctly uncommon, susceptible populations will probably increase as a consequence of the extended use of irradiation, immunosuppressive drugs, and the appearance of acquired immune deficiency syndrome (AIDS).""'5 As a result, confirmation of this diagnosis before death and investigation of PML is of increasing importance.
The only way to make such an unequivocal diagnosis is by examining biopsy specimens of diseased areas. 4 The typical neuropathological lesions and the intranuclear polyomavirus virions can be seen by light and electron microscopy,34 but these methods are not virus-type specific and electron microscopic evaluaAccepted for publication 18 August 1988 tion is cumbersome. Isolation and cultivation can also be used for virus identification, or for confirmation of the results obtained by other methods. These techniques, however, are difficult to perform, slow, and rather insensitive.4 Immunocytochemical and in situ hybridisation techniques permit direct detection of viral antigen and nucleic acids in samples and provide useful and rapid ways of detecting and identifying infected cells.""24 With proper choice of antibodies and nucleic acid probes, both techniques have, in principle, the capacity to distinguish between the different polyomaviruses.'"24 With the advent of non-radioactive labelling techniques for nucleic acids the in situ hybridisation technique is becoming routinely applicable.
We studied the brain tissue of two patients with PML using in situ and filter hybridisation techniques with acetyl aminofluorene (AAF) and radioisotope labelled viral DNA probes. In situ hybridisation was combined with immunocytochemical staining for glial fibrillary acidic protein (GFAP) to characterise the infected cell type, in addition to the use of morphological criteria. caused by Pneumocystic carinii presented with a paresis of the left arm. PML was diagnosed on a brain biopsy specimen both by electron microscopy and detection of JCV-DNA by autoradiographic dothybridisation. Thereafter, his general and neurological condition deteriorated rapidly. The patient died six months after onset of illness. At post mortem examination extensive white matter destruction was found in both hemispheres. CASE 2 A 49 year old man with non-Hodgkin's lymphoma of the right lung was diagnosed in January 1986 and treated according to the MACOP-B program. In May 1986 a tuberculosis infection located in the lymphoma was diagnosed and treated with isoniazide, pyrizinamide, and rifampicine. At this time he developed clumsiness of the left hand and over the succeeding six months he developed increasing difficulty in walking and a loss ofconcentration and memory. Neurological examination in October 1986 showed bradyphrenia, dysarthria, nystagmus on both sides, paresis of the left arm with dysdiadochokinesis and ataxia that was more pronounced on the left side. The MRI-scan showed lesions in the left frontal lobe (fig 1) and in the thalamus on the right side. Biopsy specimens were taken from the left frontal lobe. Microscopic evaluation showed changes compatible with PML with foci of demyelination, loss of oligodendrocytes, large astrocytes and a plasma cell infiltrate. Electron microscopical examination showed many polyoma virions with a diameter of about 40 nm as well as filamentous forms in a few regressively changed oligodendrocytes. The patient received two courses of treatment with arabinoside-C: day 1, 20 mg intrathecally; days 1-6, 120 mg intravenously; day 6, 20 mg intrathecally. ' Denaturation was carried out in an oven at 80°C for 10 minutes. The slides were then transfered to an incubator at 37°C and the hybridisation was allowed to continue for at least two hours up to a maximum of 20 hours. After removal of the coverslips the slides were washed in 2 x SSC/0-1% SDS (twice for 20 minutes at room temperature), 0 1 x SSC/0-1% SDS (15 minutes at room temperature), 0.1 x SSC/0-1% SDS (15 minutes at 600C), 2 x SSC/0-1% SDS (20 minutes at room temperature) and for five minutes in phosphate buffered saline (PBS). As homology between JC virus DNA and the genomes of SV40 and BKV is reported to be 69% and 75%, respectively,29 only JC virus hybrids were expected to be stable at the standard washing conditions used. To test this the stringency of washing was varied. After hybridisation with either JCV, SV40, or BKV probes, for the stringent wash, sections of PML tissue were treated with 2 x SSC/0-1% SDS for 15 minutes at room temperature, or 0 1 x SSC/0O 1% SDS for 15 minutes at room temperature, or at 400C, or 60°C, or 680C.
For immunocytochemical detection of hybrids, the slides were preincubated with 2% bovine serum albumin (BSA) in PBS for 30 minutes at room temperature and dehydrated. Detection of the AAFlabelled, in situ hybridised probe was performed by incubation of monoclonal anti-AAF antibody (1500, kindly provided by Dr RA Baan, Rijswijk, The Netherlands) for 45 minutes at 37°C in PBS/0-05% Tween-20, three washes with PBS/Tween-20, incubation with peroxidase conjugated rabbit anti-mouse Ig, and peroxidase staining for two to 10 minutes with 0-05% diamine benzidine/0-05% H20/001 M Imidazole. The slides were washed with PBS and distilled water, dehydrated, counterstained with Mayer's haematoxylin and embedded in paraffin wax. For autoradiography the slides were dipped in Kodak emulsion NBT2 at 50°C and exposed for between six and 12 hours at 4°C. The slides were developed with Kodak D19 developer for five minutes, washed in distilled water, and fixed in 10% Agefix (AGFAGevaert, Leverkusen, West Germany) for five minutes.
For combined GFAP staining and in situ hybridisation, GFAP immunocytochemistry was performed before in situ hybridisation.
IMMUNOCYTOCHEMICAL GFAP STAINING GFAP labelling was used to identify astrocytes. The immunoperoxidase staining was done as described above with polyclonal rabbit anti-GFAP (1/50, Eurodiagnostics, Apeldoorn, The Netherlands) for 45 minutes at 37°C and peroxidase conjugated goat antirabbit Ig (1/100 Sanbio) for 45 minutes at 37°C.
DOT AND SOUTHERN HYBRIDISATION
Filter hybridisation Isolated DNA was denatured for five minutes at 100°C, quenched on ice, and a volume of 1 pl was spotted on nitrocellulose filters (Sartorius) previously wetted in 2 x SSC. Total human DNA was used as a negative control and cloned JC virus DNA as a positive control. The filter was air dried and baked for two hours at 80°C. Non-radioactive filter hybridisation was performed by preincubating the filters with 3 x SSC, 0-1% polyvinyl pyeolidon (PVP)/Ficoll, 0-2% BSA, and 500 pg/mI sheared herring sperm DNA for one hour at 60°C and incubation with 3 x SSC, 0.02% PVP/Ficoll, 0-04% BSA, 5% dextran sulphate and 300 pg/ml sheared herring sperm DNA for 30 minutes at 60°C. The AAF-modified probe was denatured for four minutes at 100°C, quenched on ice, and added to a final concentration of 250 ng/ml. Overnight hybridisation was carried out at 60°C with continuous shaking. The filters were washed three times with 2 x SSC at 60°C for 15 minutes, twice with I x SSC at 60°C for five minutes, twice with 0-3 x SSC at 60°C for five minutes, once with 0-1 x SSC at 60°C for five minutes, once with -2 x SSC at room temperature and dried on filter paper. Immunoenzymic detection was carried out by preincubating the filters with 1% PVP/Ficoll, 1% BSA ; * J f * * _ ; " s j > ' @ . ; i i > : ¢ t @ ; 4 -g * ; = 4 . * t . * , + + : ; * * * | * T * . ; W The observed difference in percentage of infected cells between material from the two patients is probably a reflection of the clinical stage of the disease, the process being more diffuse and extensive in case 1.
The results obtained on material from case 2 provide an example of the usefulness of non-radioactive in situ hybridisation for the diagnosis of PML before death. It also shows the power of this technique in combining structural and biochemical information. Furthermore, it permits relatively easy and fast detection of only a few infected cells in a small biopsy sample.
The clinical course of case 2 is remarkable as he remained in a stable and relatively good condition until 12 months after onset of disease. Perhaps the plasma cells seen in the biopsy specimen from this patient can be interpreted as an immune response mounted against the virus. The combined quantitation and localisation of JC virus in single cells is important for studying the pathogenesis of PML, which could be the result of reactivation of a latent virus in an immune compromised patient.4 Although evidence of the presence of latest JC virus in other organs is available3" 3"2 and excretion in the urine has been found,4" the clinical importance of these findings is not clear. Hybridisation techniques can be used to scan the body for the presence of viral DNA40 and to pinpoint the virus to certain cell types. Investigation of JC virus isolates with restriction enzymes also suggests that these subtypes circulate, with some heterogeneity of DNA isolated from different organs.404247 As shown by the Southern filter hybridised with AAF labelled probe, problems concerning the molecular epidemiology of JC virus can be studied using non-radioactive hybridisation techniques. Research of various aspects of JC virus is important as it may have other effects as exemplified by the study of the oncogenic potential of JC virus in experimental animals. 48 The detection of polyomavirus using AAF labelled probes can be used to establish rapidly the diagnosis of PML both in biopsy and necropsy material. The disease might become treatable if more effective antiviral drugs are developed. Therefore the application of in situ hybridisation for rapid, early diagnosis of PML in brain tissue is strongly recommended.
This study was supported in part by the "Stichting Prof AAH Kassenaar Fonds" at the Medical Faculty of the University of Leiden, The Netherlands. group.bmj.com on May 30, 2017 -Published by http://jcp.bmj.com/ Downloaded from exposure to alkylating agents of different origin, from dietary to occupational, to meditinal. Details on all the currently available techniques for the detection of DNA adducts are given, and it is interesting and encouraging to see that, since the last meeting in 1983, progress has been made in the application of such techniques to the measurement of DNA damage in human populations, as reported by several authors.
Limited space, however, is devoted to epidemiological studies and only a few chapters discuss the link between DNA adduct detection and risk assessment. Furthermore, the absence of reports on strategies ofcancer prevention was most disappointing. It would have been of great interest, as anticipated in the title, to learn how the existing techniques could be applied to the prevention of some environmental cancers.
Despite these shortcomings, the book offers comprehensive and updated information on the latest achievements in molecular dosimetry studies and provides.some useful reading to scientists involved in this field of research. 
Corrections
Dr JW Keyser's authorship was omitted from the book Human Plasma Proteins, a review of which was published in this Journal.
In the summary of the paper, Diagnosis of progress in multifocal leucoencephalopathy by hybridisation techniques, the studied material from the second patient was incorrectly stated as being from a necropsy specimen: it was, in fact, obtained from a brain biopsy specimen. ( that Volume 78 "thoroughly reviews the pathogenesis of metastasis and the unique properties of highly malignant cells and their microenvironment" and that Volume 79 "comprehensively explores the underlying regulation of altered glycosylation after oncogenic transformation and the functional significance of these changes". As suggested by Professor Weiss, it is highly likely that the meetings were useful forums for the exchange of new data and views, but the books, although well presented, do not live up to these rather ambitious claims. Some papers in both books describe interesting and well performed studies. But many contain preliminary data or, in some cases, brief reviews of the work of a particular laboratory. In some cases the latter is little more than ex cathedra statement with little reference to the work of other groups.
Of particular concern is the fact that 126 pages (39-1 %) of Volume 78 and 205 pages (58 6%) of Volume 79 have been published in the Journal ofCellular Biochemistry (Alan R Liss Inc) in exacdy the same format. Indeed, in both volumes these pages are paginated twice, once for the book and once with the journal page numbers. These books each cost $140, and since, in general, the useful papers were the ones that have previously appeared in the Journal of Cellular Biochemistry, we find it difficult to imagine who would buy them. 
In the summary of the paper, Diagnosis of progress in multifocal leucoencephalopathy by hybridisation techniques, the studied material from the second patient was incorrectly stated as being from a necropsy specimen: it was, in fact, obtained from a brain biopsy specimen. 
